<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1432</number>
    <updateDate>2023-01-11T19:54:19Z</updateDate>
    <updateDateIncludingText>2023-01-11T19:54:19Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2007-03-09</introducedDate>
    <congress>110</congress>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif17</systemCode>
            <name>Innovation, Data, and Commerce Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2007-03-12T19:40:53Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2007-03-09T14:02:50Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2007-03-09T14:03:00Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Preserve Access to Affordable Generics Act</title>
        <congress>110</congress>
        <number>316</number>
        <type>S</type>
        <latestAction>
          <actionDate>2007-03-07</actionDate>
          <text>Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2007-03-12</actionDate>
        <committees>
          <item>
            <systemCode>hsif17</systemCode>
            <name>Innovation, Data, and Commerce Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Commerce, Trade and Consumer Protection.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2007-03-09</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2007-03-09</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100-A</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2007-03-09</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2007-03-09</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2007-03-09</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>W000215</bioguideId>
        <fullName>Rep. Waxman, Henry A. [D-CA-30]</fullName>
        <firstName>HENRY</firstName>
        <lastName>WAXMAN</lastName>
        <party>D</party>
        <state>CA</state>
        <middleName>A.</middleName>
        <district>30</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>V000128</bioguideId>
        <fullName>Rep. Van Hollen, Chris [D-MD-8]</fullName>
        <firstName>Chris</firstName>
        <lastName>Van Hollen</lastName>
        <party>D</party>
        <state>MD</state>
        <district>8</district>
        <sponsorshipDate>2007-09-24</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Commerce</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Antitrust law</name>
        </item>
        <item>
          <name>Competition</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Generic drugs</name>
        </item>
        <item>
          <name>Health</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Marketing</name>
        </item>
        <item>
          <name>Patent infringement</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Restrictive trade practices</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Commerce</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2007-03-09</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2007-05-04T13:52:45Z</updateDate>
        <text><![CDATA[ <p>Preserve Access to Affordable Generics Act - Amends the Clayton Act to make it unlawful for a person, in connection with the sale of a drug product, to be a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market, or sell the generic product for any period. Excludes a resolution or settlement that includes no more than the right to market the generic product prior to the expiration of the patent.</p> <p>Amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to set forth additional filing requirements related to agreements between a brand name drug company and a generic drug applicant. Requires the Chief Executive Officer or the company official responsible for negotiating any agreement to file a certification that materials filed with respect to such agreements are complete, final, and exclusive.</p> <p>Amends the Federal Food, Drug, and Cosmetic Act to provide that forfeiture of the 180-day exclusivity period for the marketing of a generic drug occurs if there is a final decision of the Federal Trade Commission (FTC) or the court that an agreement has violated this Act.</p>]]></text>
      </summary>
    </summaries>
    <title>Preserve Access to Affordable Generics Act</title>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>Preserve Access to Affordable Generics Act</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Preserve Access to Affordable Generics Act</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2007-03-09T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110hr1432ih/xml/BILLS-110hr1432ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2007-03-12</actionDate>
      <text>Referred to the Subcommittee on Commerce, Trade and Consumer Protection.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
